Historical record - last NADAC effective date: 7/17/2019
Product Information
ALOCRIL 2% EYE DROPS is a brand product labeled by Allergan, Inc., priced at $40.9824 per ML under NDC 00023884205. Its NADAC has been published 322 times since Nov 28, 2013.
FDA first approved this application on Dec 8, 1999.
Strength
20 mg/mL
Manufacturer
Allergan, Inc.NDC
00023884205
Classification
Brand
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
7/17/2019
Active Ingredients
NEDOCROMIL SODIUMApproval Type
New Drug (NDA)
FDA Application
NDA021009FDA Approved
12/8/1999
On Market Since
2/3/2000
Pharmacological Classes
Price Statistics
The NADAC for ALOCRIL 2% EYE DROPS has been published 322 times since Nov 28, 2013, and over the history we have for it it has risen 66.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $40.9824 per ML |
|---|---|
| All-time high | $41.7900 (Jan 16, 2019) |
| All-time low | $24.6084 (Nov 28, 2013) |
| Median price | $34.8536 |
| Average price | $35.2803 |
| Largest weekly change | +10.0% (Jan 14, 2015) |
| Weeks tracked | 322 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+66.5%
Last surveyed Jul 15, 2020 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the nedocromil sodium market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Allergan, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
nedocromil sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Mast Cell Stabilizer class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ALOCRIL 2% EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for ALOCRIL 2% EYE DROPS, manufactured by Allergan, Inc., is $40.9824 per ML (NDC 00023884205), effective Jul 15, 2020.
How has the price of ALOCRIL 2% EYE DROPS changed over time?
Over the history we have for it, the NADAC for ALOCRIL 2% EYE DROPS has risen 66.5%. It has been tracked across 322 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ALOCRIL 2% EYE DROPS?
Since Nov 28, 2013, the NADAC for ALOCRIL 2% EYE DROPS has ranged from a low of $24.6084 (Nov 28, 2013) to a high of $41.7900 (Jan 16, 2019), with a median of $34.8536 per ML.
Are there cheaper alternatives to ALOCRIL 2% EYE DROPS?
No other NADAC-published product currently shares the active ingredient and strength of ALOCRIL 2% EYE DROPS in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ALOCRIL 2% EYE DROPS?
ALOCRIL 2% EYE DROPS (NDC 00023884205) is labeled by Allergan, Inc., and CMS classifies it as a brand product.